Injectable hydrogels based on MPEG-PCL-RGD and BMSCs for bone tissue engineering.

Area of Science:

• Biomaterials Science
• Stem Cell Biology
• Tissue Engineering

Background:

• Bone marrow-derived mesenchymal stem cells (BMSCs) are crucial for bone regeneration.
• Developing effective delivery systems for BMSCs is essential for bone tissue engineering.
• Thermosensitive in situ forming hydrogels offer promising platforms for cell delivery and tissue repair.

Purpose of the Study:

• To evaluate the osteogenic potential of BMSCs on methoxy polyethylene glycol-polycaprolactone (MP) and RGD-conjugated MP (MP-RGD) hydrogels.
• To assess the efficacy of MP/MP-RGD hydrogels in promoting bone formation in vitro and in vivo.

Main Methods:

• BMSCs were seeded on MP and MP-RGD hydrogels.
• Osteogenic marker expression was analyzed using real-time PCR and immunofluorescence staining.
• Gene expression profiling and pathway analysis (Kyoto Encyclopedia of Genes and Genomes) were performed.
• Bone regeneration was evaluated in a rabbit calvarial defect model using histology and computed tomography.

Main Results:

• MP/MP-RGD hydrogels significantly upregulated osteogenic markers (collagen 1, osteocalcin) in BMSCs.
• Gene expression analysis revealed enhanced cell proliferation and differentiation signaling pathways.
• In vivo studies demonstrated substantial new bone formation in MP/MP-RGD treated defects.
• Histological and CT analyses confirmed the positive effect of MP/MP-RGD hydrogels on bone regeneration.

Conclusions:

• The RGD-conjugated thermosensitive hydrogel (MP-RGD) effectively supports BMSC osteogenic differentiation.
• MP/MP-RGD hydrogels promote significant new bone formation, indicating potential for bone tissue regeneration.
• These hydrogel systems show promise for enhancing bone repair strategies.